| Business

Become a contributor

Bookmark Econotimes

| Business

Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies

Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit

Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026

SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off

CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences

AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock

Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks

Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings

Instagram Outage Disrupts Thousands of U.S. Users

Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised

Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch

Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains

Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations

Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links

SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO

Ford and Geely Explore Strategic Manufacturing Partnership in Europe

Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence

©Econometrics LLC . All Rights Reserved.

NICOX : Issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to former Aciex shareholders following the US FDA's approval of ZERVIATE

Thursday, June 8, 2017 11:06 PM UTC

Attachments:

http://www.globenewswire.com/NewsRoom/AttachmentNg/f9951bd3-f92b-4f37-8042-b159f0de47b3

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Market Data

Bhutan Dumps $22.4M Bitcoin: Sovereign Wallet Sales Signal Strategic Trim in Shrinking $412M Portfolio

Vitalik Buterin Sells $6.6M ETH Amid Crash — But It's All for Charity

Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit

FxWirePro- Major Crypto levels and bias summary

FxWirePro- Key Crypto Updates

Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions

BOE Holds & Hints at Future Cuts – EURGBP Rockets Higher, Eyes 0.8750+ on 0.8725 Break

Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions

Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border

EconoTimes

Disclaimer: EconoTimes provides references and links to selected blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the blogs or other sources of information. Clients and prospects are advised to carefully consider the opinions and analysis offered in the blogs or other information sources in the context of the client or prospect's individual analysis and decision making. None of the blogs or other sources of information is to be considered as constituting a track record. Past performance is no guarantee of future results and EconoTimes specifically advises clients and prospects to carefully review all claims and representations made by advisors, bloggers, money managers and system vendors before investing any funds or opening an account with any Brokerage. Any news, opinions, research, data, or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. EconoTimes expressly disclaims any liability for any lost principal or profits without limitation which may arise directly or indirectly from the use of or reliance on such information. As with all such advisory services, past results are never a guarantee of future results.

NICOX : Issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to former Aciex shareholders following the US FDA's approval of ZERVIATE

Editor's Picks

Welcome to EconoTimes